The EU has announced plans to buy 1.8 billion doses of the BioNTech-Pfizer vaccine through 2023. The bloc is also bringing forward shorter-term Pfizer deliveries after suspending orders for the Johnson & Johnson.
On Wednesday, European Commission head Ursula von der Leyen said the EU planned to order 1.8 billion doses of the BioNTech-Pfizer vaccine by 2023.
Von der Leyen said Brussels had full confidence in the technology behind the Pfizer vaccine. The manufacturing process used for the Pfizer product — dependent on mRNA — is different then the one behind the Oxford-AstraZeneca jab, which uses a cold virus to transport a segment of the coronavirus to the recipients' cells.
Read more at:
EU puts faith in Pfizer jab with plan for 1.8 billion doses | Europe| News and current affairs from around the continent | DW | 14.04.2021
